Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 18, 2026

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

The national temporal lobectomy survey.

David F Demase1, Michael Gruenthal, John Balint

  • 1Albany Medical College, Alden March Bioethics Institute, Albany, NY 12208, USA. demased@hotmail.com

Seizure
|November 26, 2009
PubMed
Summary

Physicians lack consistent criteria for temporal lobectomy, impacting epilepsy surgery outcomes. Developing a unified approach is crucial for managing pharmacoresistant epilepsy effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging devices for epilepsy.

Neurology. Clinical practice·2018
Same author

Noninflammatory Changes of Microglia Are Sufficient to Cause Epilepsy.

Cell reports·2018
Same author

Comment: should we induce ketosis in super-refractory status epilepticus?

Neurology·2014
Same author

From patterns to patients: what can we tell people with newly diagnosed epilepsy?

Neurology·2012
Same author

Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy.

Neurobiology of disease·2010
Same author

Infant botulism: two recent cases and literature review.

Journal of child neurology·2008

Area of Science:

  • Neurology
  • Neurosurgery

Background:

  • Temporal lobectomy is a key treatment for pharmacoresistant epilepsy.
  • Current practices for patient selection and evaluation vary significantly among specialists.

Purpose of the Study:

  • To assess current selection criteria for temporal lobectomy.
  • To evaluate pre-surgical evaluation, informed consent, and success definitions.

Main Methods:

  • An electronic survey with 26 questions was developed.
  • The survey was distributed to epileptologists and neurosurgeons at 105 US epilepsy centers.

Main Results:

  • Variations exist in defining pharmacoresistance and surgical candidacy.
  • Definitions of successful epilepsy surgery and appropriate preoperative tests differ.
  • Informed consent processes are inconsistently thorough.

Conclusions:

  • The neurological community lacks consistent definitions and practices for managing pharmacoresistant epilepsy.
  • A unified approach is needed to standardize temporal lobectomy management and improve patient outcomes.

More Related Videos

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

Related Experiment Videos

Last Updated: Jun 18, 2026

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016